This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY009 PET Imaging in patients
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
10
Patients will receive a tracer (5-10mg, IV) dose of 89Zr (2-3mCi) labelled NY009
Affiliated Hospital of Jiangnan University
Wuxi, China
RECRUITINGEvaluation of tissue distribution of 89Zr-NY009
Biodistribution of 89Zr-NY009 evaluated by radioactive uptake values (standardized uptake values, SUVs) in various organs during repeated 89Zr-PET scans will be reported.
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.